A Study of Renal Microvessel Imaging for Chronic Kidney Disease
Launched by MAYO CLINIC · Feb 28, 2023
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Healthy volunteers or Chronic Kidney Disease (CKD) patients with clinically indicated renal biopsy.
- Exclusion Criteria:
- • Subjects lacking capacity to consent.
- • Vulnerable subjects such as prisoners; pregnant women; nursing mother.
- • Subjects with history of hypersensitivity allergic reactions to ultrasound contrast agents.
- • Patients with high-risk cardiac diseases.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Shigao Chen, PhD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials